UPDATED Aug 11, 2022
Discover large cap U.K. Pharmaceuticals & Biotech companies that are on the FTSE. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AZNAstraZeneca | UKĀ£105.06 | -2.0% | 26.6% | UKĀ£162.8b | UKĀ£119.25 | PS4.5x | E29.3% | 2.1% | ||
| GSKGSK | UKĀ£14.00 | -15.6% | -24.0% | UKĀ£56.7b | UKĀ£20.38 | PE12.4x | E8.5% | 7.1% | ||
| DPHDechra Pharmaceuticals | UKĀ£36.56 | -3.4% | -28.3% | UKĀ£4.2b | UKĀ£45.10 | PE57.1x | E12.4% | 1.1% | ||
| HIKHikma Pharmaceuticals | UKĀ£15.65 | -5.2% | -38.5% | UKĀ£3.4b | UKĀ£23.43 | PE12.2x | E7.5% | 2.9% | ||
| ABCAbcam | UKĀ£12.53 | -1.9% | -15.5% | UKĀ£2.9b | UKĀ£15.15 | PE651.2x | E36.0% | 0% | ||
| ONTOxford Nanopore Technologies | UKĀ£3.35 | 7.7% | n/a | UKĀ£2.8b | UKĀ£5.80 | PS20.6x | E33.7% | n/a | ||
| INDVIndivior | UKĀ£3.05 | -6.8% | 86.5% | UKĀ£2.1b | UKĀ£3.95 | PE17x | E14.4% | 0% | ||
| HCMHUTCHMED (China) | UKĀ£2.25 | 8.4% | -62.2% | UKĀ£1.9b | UKĀ£3.82 | PS5.8x | E35.4% | n/a | ||
| GNSGenus | UKĀ£27.64 | -2.5% | -52.2% | UKĀ£1.8b | UKĀ£46.35 | PE48.7x | E18.6% | 1.1% | ||
| PRTCPureTech Health | UKĀ£2.27 | 16.4% | -30.2% | UKĀ£645.5m | UKĀ£6.62 | PS45.3x | E-16.4% | n/a | ||
| ERGOErgomed | UKĀ£12.50 | -4.0% | -0.4% | UKĀ£624.1m | UKĀ£14.25 | PE49.2x | E15.0% | n/a | ||
| APHAlliance Pharma | UKĀ£0.93 | -2.0% | -14.7% | UKĀ£502.0m | UKĀ£1.37 | PE68.6x | E21.2% | 1.8% | ||
| OXBOxford Biomedica | UKĀ£4.92 | -2.8% | -64.2% | UKĀ£472.7m | UKĀ£12.25 | PE24.9x | E-2.5% | n/a | ||
| MXCTMaxCyte | UKĀ£4.81 | 2.9% | -58.2% | UKĀ£452.6m | UKĀ£9.86 | PS14.4x | E15.2% | n/a | ||
| AVCTAvacta Group | UKĀ£1.12 | -2.2% | -5.9% | UKĀ£280.1m | UKĀ£1.87 | PS95.3x | E1.9% | n/a | ||
| REDXRedx Pharma | UKĀ£0.62 | 0.8% | 9.7% | UKĀ£206.7m | UKĀ£1.55 | PS12.7x | E-15.4% | n/a | ||
| BVXPBioventix | UKĀ£33.75 | -1.5% | -14.0% | UKĀ£175.8m | UKĀ£43.00 | PE26.6x | E0.04% | 4.2% | ||
| ANCRAnimalcare Group | UKĀ£2.88 | 0% | -20.4% | UKĀ£172.8m | UKĀ£4.42 | PS2.3x | S3.2% | 1.7% | ||
| CIRCircassia Group | UKĀ£0.34 | -2.6% | -17.3% | UKĀ£143.0m | n/a | PE62.2x | E23.6% | n/a | ||
| AGYAllergy Therapeutics | UKĀ£0.20 | 3.9% | -34.7% | UKĀ£127.2m | n/a | PS1.6x | E41.5% | n/a | ||
| SARSareum Holdings | UKĀ£1.68 | -6.7% | -62.5% | UKĀ£114.4m | n/a | PB20.1x | E-31.4% | n/a | ||
| FARNFaron Pharmaceuticals Oy | UKĀ£2.03 | 3.8% | -54.5% | UKĀ£111.9m | UKĀ£3.98 | PB45.3x | E-0.001% | n/a | ||
| ETXe-therapeutics | UKĀ£0.21 | 1.0% | -18.1% | UKĀ£108.1m | n/a | PS228.3x | n/a | n/a | ||
| FUMFutura Medical | UKĀ£0.36 | -0.6% | -7.3% | UKĀ£103.4m | UKĀ£1.09 | PB10.6x | n/a | n/a |